Oxycodone on Packaging Line Leads to Recall of Betaxolol
Betaxolol may cause a slowing in the heart rate in some patients; an opioid could increase the effect.
KVK-Tech is voluntarily recalling one lot of Betaxolol Tablets, USP 10 mg, which is a beta blocker used to treat patients with hypertension and also used to treat glaucoma. The company is making the recall as a precautionary measure after one tablet Oxycodone HCl tablet 5 mg was found on the packaging line of Betaxolol.
KVK has not received any reports of foreign tablet in any bottle of Betaxolol.
Betaxolol has a warning on its label about the possibility of a slowing in the heart rate in elderly patients. This effect could be increased by inadvertent opioid administration. Additionally, some patients prescribed low-dose betaxolol might be have compromised heart and lung function that is also likely to be exacerbated by an opioid, the company said.
The affected Betaxolol has a lot number of 17853A and has an expiration date of June 2027. The batch was distributed nationwide to wholesalers and retailers.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
